Antibody Information
General Information of This Antibody
| Antibody ID | ANTI0GKVVK |
|||||
|---|---|---|---|---|---|---|
| Antibody Name | EDB- (kK183C-K290C) |
|||||
| Organization | Pfizer Inc. |
|||||
| Synonyms |
EDB- (kK183C-K290C)
Click to Show/Hide
|
|||||
| Antibody Type | Monoclonal antibody (mAb) |
|||||
| Antibody Subtype | Humanized lgG |
|||||
| Antigen Name | Vesicle-associated membrane protein 8 (VAMP8) |
Antigen Info | ||||
| Click to Show/Hide the Sequence Information of This Antibody | ||||||
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
EDB- (κK183C-K290C)-vc-0101 [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
198 ng/mL
|
Positive EDB expression (EDB+++/++) | ||
| Method Description |
Calculated using four-parameter logistic model #203 with XLfit v4.2 (IDBS)
|
||||
| In Vitro Model | Normal | WI38-VA13 cells | CVCL_2759 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
9276 ng/mL
|
Negative EDB expression (EDB-) | ||
| Method Description |
Calculated using four-parameter logistic model #203 with XLfit v4.2 (IDBS)
|
||||
| In Vitro Model | Colon cancer | HT29 cells | CVCL_A8EZ | ||